S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
S&P 500   2,659.41 (-0.16%)
DOW   22,653.86 (-0.12%)
QQQ   196.40 (-0.04%)
AAPL   259.43 (-1.16%)
FB   168.83 (+1.98%)
MSFT   163.49 (-1.08%)
AMZN   2,011.60 (+0.70%)
CGC   14.50 (+1.12%)
NVDA   259.03 (-3.49%)
BABA   198.00 (+0.79%)
MU   46.54 (+0.37%)
GE   7.03 (-2.77%)
TSLA   545.45 (+5.66%)
AMD   47.56 (+0.08%)
T   30.08 (+2.17%)
ACB   0.80 (+0.00%)
F   4.71 (+3.97%)
NFLX   372.28 (-2.02%)
BAC   22.14 (+3.51%)
GILD   74.67 (-3.94%)
DIS   101.24 (+1.67%)
PRI   88.06 (+1.11%)
Log in

NASDAQ:ODTOdonate Therapeutics News Headlines

$26.54
-1.04 (-3.77 %)
(As of 04/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$25.80
Now: $26.54
$28.19
50-Day Range
$20.22
MA: $27.62
$34.59
52-Week Range
$16.50
Now: $26.54
$43.75
Volume36,720 shs
Average Volume93,823 shs
Market Capitalization$850.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Headlines

Odonate Therapeutics (NASDAQ ODT) News Headlines

Source:
DateHeadline
-$1.02 EPS Expected for Odonate Therapeutics Inc (NASDAQ:ODT) This Quarter-$1.02 EPS Expected for Odonate Therapeutics Inc (NASDAQ:ODT) This Quarter
www.americanbankingnews.com - March 28 at 9:55 AM
Odonate Therapeutics Inc (NASDAQ:ODT) Given Consensus Recommendation of "Hold" by BrokeragesOdonate Therapeutics Inc (NASDAQ:ODT) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 28 at 2:06 AM
Odonate Therapeutics Inc (NASDAQ:ODT) Sees Significant Decrease in Short InterestOdonate Therapeutics Inc (NASDAQ:ODT) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - March 27 at 5:30 AM
Odonate Therapeutics Sees Hammer Chart Pattern: Time to Buy?Odonate Therapeutics Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - March 25 at 8:42 AM
Twelve Months EndedTwelve Months Ended
www.businesswire.com - February 20 at 12:54 PM
We're Not Very Worried About Odonate Therapeutics's (NASDAQ:ODT) Cash Burn RateWe're Not Very Worried About Odonate Therapeutics's (NASDAQ:ODT) Cash Burn Rate
finance.yahoo.com - February 11 at 12:13 PM
Hedge Funds Have Never Been This Bullish On Odonate Therapeutics, Inc. (ODT)Hedge Funds Have Never Been This Bullish On Odonate Therapeutics, Inc. (ODT)
finance.yahoo.com - October 28 at 5:42 PM
Odonate Therapeutics Announces Completion of Enrollment in CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast CancerOdonate Therapeutics Announces Completion of Enrollment in CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer
finance.yahoo.com - October 21 at 1:22 PM
Odonate Therapeutics Enters Oversold TerritoryOdonate Therapeutics Enters Oversold Territory
finance.yahoo.com - September 30 at 5:06 PM
4 of the Best Stocks With Solid Earnings Acceleration4 of the Best Stocks With Solid Earnings Acceleration
finance.yahoo.com - September 27 at 3:44 PM
Odonate down 1% premarket on bearish Empire callOdonate down 1% premarket on bearish Empire call
seekingalpha.com - August 27 at 9:54 AM
ODT: Insiders vs. ShortsODT: Insiders vs. Shorts
www.nasdaq.com - August 6 at 11:49 PM
Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019
finance.yahoo.com - July 24 at 9:49 AM
Heres Why Odonate Therapeutics Stock Jumped 70.7% in JuneHere's Why Odonate Therapeutics Stock Jumped 70.7% in June
finance.yahoo.com - July 9 at 9:36 AM
Here's Why Odonate Therapeutics Stock Jumped 70.7% in JuneHere's Why Odonate Therapeutics Stock Jumped 70.7% in June
finance.yahoo.com - July 9 at 9:36 AM
Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $20 million of SharesOdonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $20 million of Shares
finance.yahoo.com - June 29 at 9:20 AM
Odonate Therapeutics prices follow-on offering at $26/shareOdonate Therapeutics prices follow-on offering at $26/share
seekingalpha.com - June 26 at 5:33 PM
Odonate Therapeutics: Making Taxanes Orally AvailableOdonate Therapeutics: Making Taxanes Orally Available
seekingalpha.com - June 26 at 5:33 PM
Odonate Therapeutics Announces Pricing of Public Offering of Shares of Common StockOdonate Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
finance.yahoo.com - June 26 at 9:36 AM
Odonate Therapeutics Announces Public Offering of Shares of Common StockOdonate Therapeutics Announces Public Offering of Shares of Common Stock
finance.yahoo.com - June 25 at 6:13 PM
Independent Data Monitoring Committee (IDMC) Recommends CONTESSA Continue with No Modifications following Planned Interim Efficacy Futility AnalysisIndependent Data Monitoring Committee (IDMC) Recommends CONTESSA Continue with No Modifications following Planned Interim Efficacy Futility Analysis
finance.yahoo.com - June 3 at 9:23 AM
Odonate Therapeutics to Present at the Jefferies 2019 Global Healthcare ConferenceOdonate Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 29 at 9:27 AM
Jazz Pharma (JAZZ) Q1 Earnings and Sales Beat EstimatesJazz Pharma (JAZZ) Q1 Earnings and Sales Beat Estimates
finance.yahoo.com - May 8 at 9:25 AM
Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019
finance.yahoo.com - April 25 at 9:27 AM
Tesetaxel Brain Concentrations Exceeded Concentrations Required for Tumor Killing for Sustained Period of Time in Preclinical TestingTesetaxel Brain Concentrations Exceeded Concentrations Required for Tumor Killing for Sustained Period of Time in Preclinical Testing
finance.yahoo.com - April 2 at 10:56 AM
Odonate Therapeutics Initiates CONTESSA TRIOOdonate Therapeutics Initiates CONTESSA TRIO
finance.yahoo.com - March 28 at 9:42 AM
Have Insiders Been Buying Odonate Therapeutics, Inc. (NASDAQ:ODT) Shares?Have Insiders Been Buying Odonate Therapeutics, Inc. (NASDAQ:ODT) Shares?
finance.yahoo.com - March 14 at 6:22 PM
Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $2.6 million of SharesOdonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $2.6 million of Shares
finance.yahoo.com - March 12 at 10:33 AM
Odonate Therapeutics to Present at the Cowen and Company 39th Annual Health Care ConferenceOdonate Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 6 at 6:25 PM
Odonate launches mid-stage study of tesetaxel in breast cancerOdonate launches mid-stage study of tesetaxel in breast cancer
seekingalpha.com - March 4 at 6:36 PM
Odonate Therapeutics Announces Initiation of CONTESSA 2, a Phase 2 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a TaxaneOdonate Therapeutics Announces Initiation of CONTESSA 2, a Phase 2 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane
finance.yahoo.com - March 4 at 6:36 PM
Odonate Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2019Odonate Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2019
finance.yahoo.com - February 28 at 9:32 AM
Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018
finance.yahoo.com - February 22 at 10:18 AM
Odonate Therapeutics: Small Biotech Firm Seeks To Improve Quality Of Life For Breast Cancer PatientsOdonate Therapeutics: Small Biotech Firm Seeks To Improve Quality Of Life For Breast Cancer Patients
seekingalpha.com - January 7 at 9:14 AM
Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $586,800 of SharesOdonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $586,800 of Shares
finance.yahoo.com - December 19 at 9:29 AM
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Featured Article: SEC Filing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel